Portico Next Generation Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 333 participants.
Also called NCT04011722
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 333 participants
- Sponsor
- Registry
-
NCT04011722
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Australia, Denmark, Italy, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04011722. Non-randomized; no masking; primary purpose treatment. Start 2019-09-17 (actual); primary completion 2023-01-12 (actual). Results posted on 2024-07-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Portico Next Generation Approval Study
- Condition
- Symptomatic Severe Aortic Stenosis
- Intervention (Device)
- Portico™ NG (Navitor) Valve and FlexNav™ Delivery System
- Intervention (Device)
- Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04011722- Content hash
a1ac592c48c8442009ebbfb3f11136ebb7fa3e9d5a59f3f0e87ddd38c63dd80c